BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 38726720)

  • 21. Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis: a systematic review and meta-analysis.
    Swift SL; Puehler T; Misso K; Lang SH; Forbes C; Kleijnen J; Danner M; Kuhn C; Haneya A; Seoudy H; Cremer J; Frey N; Lutter G; Wolff R; Scheibler F; Wehkamp K; Frank D
    BMJ Open; 2021 Dec; 11(12):e054222. PubMed ID: 34873012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease.
    Ten Berg J; Sibbing D; Rocca B; Van Belle E; Chevalier B; Collet JP; Dudek D; Gilard M; Gorog DA; Grapsa J; Grove EL; Lancellotti P; Petronio AS; Rubboli A; Torracca L; Vilahur G; Witkowski A; Mehilli J
    Eur Heart J; 2021 Jun; 42(23):2265-2269. PubMed ID: 33822924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-procedural abnormal function of von Willebrand Factor is predictive of bleeding after surgical but not transcatheter aortic valve replacement.
    Grodecki K; Zbroński K; Przybyszewska-Kazulak E; Olasińska-Wiśniewska A; Wilimski R; Rymuza B; Scisło P; Czub P; Koper D; Kochman J; Pawlak K; Ciepiela O; Grygier M; Jemielity M; Lesiak M; Filipiak KJ; Opolski G; Huczek Z
    J Thromb Thrombolysis; 2019 Nov; 48(4):610-618. PubMed ID: 31359325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
    Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
    Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Factors for Post-TAVI Bleeding According to the VARC-2 Bleeding Definition and Effect of the Bleeding on Short-Term Mortality: A Meta-analysis.
    Wang J; Yu W; Jin Q; Li Y; Liu N; Hou X; Yu Y
    Can J Cardiol; 2017 Apr; 33(4):525-534. PubMed ID: 28256429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mid-term study of transcatheter aortic valve implantation in an Asian population with severe aortic stenosis: two-year Valve Academic Research Consortium-2 outcomes.
    Chew N; Hon JK; Yip WL; Chan SP; Poh KK; Kong WK; Teoh KL; Yeo TC; Tan HC; Tay EL
    Singapore Med J; 2017 Sep; 58(9):543-550. PubMed ID: 27516113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How TAVI registries report clinical outcomes-A systematic review of endpoints based on VARC-2 definitions.
    Zhang S; Kolominsky-Rabas PL
    PLoS One; 2017; 12(9):e0180815. PubMed ID: 28910289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence, Predictors, and Prognostic Impact of Bleeding Events After TAVR According to VARC-3 Criteria.
    Avvedimento M; Real C; Nuche J; Farjat-Pasos J; Galhardo A; Trinh KH; Robichaud M; Delarochellière R; Paradis JM; Poulin A; Dumont E; Kalavrouziotis D; Mohammadi S; Côté M; Rodés-Cabau J
    JACC Cardiovasc Interv; 2023 Sep; 16(18):2262-2274. PubMed ID: 37676226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence, Predictors and Impact of Severe Periprocedural Bleeding According to VARC-2 Criteria on 1-Year Clinical Outcomes in Patients After Transcatheter Aortic Valve Implantation.
    Kochman J; Rymuza B; Huczek Z; Kołtowski Ł; Ścisło P; Wilimski R; Ścibisz A; Stanecka P; Filipiak KJ; Opolski G
    Int Heart J; 2016; 57(1):35-40. PubMed ID: 26673439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodynamic durability of transcatheter aortic valves using the updated Valve Academic Research Consortium-2 criteria.
    Kumar A; Sato K; Banerjee K; Narayanswami J; Betancor J; Menon V; Mohananey D; Anumandla AK; Sawant AC; Krishnaswamy A; Tuzcu EM; Jaber W; Mick S; Svensson LG; Popović ZB; Blackstone EH; Kapadia SR
    Catheter Cardiovasc Interv; 2019 Mar; 93(4):729-738. PubMed ID: 30312995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research.
    ; Généreux P; Piazza N; Alu MC; Nazif T; Hahn RT; Pibarot P; Bax JJ; Leipsic JA; Blanke P; Blackstone EH; Finn MT; Kapadia S; Linke A; Mack MJ; Makkar R; Mehran R; Popma JJ; Reardon M; Rodes-Cabau J; Van Mieghem NM; Webb JG; Cohen DJ; Leon MB
    Eur Heart J; 2021 May; 42(19):1825-1857. PubMed ID: 33871579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcatheter aortic valve implantation: Update in 2018.
    Perrin N; Frei A; Noble S
    Eur J Intern Med; 2018 Sep; 55():12-19. PubMed ID: 30180946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Edwards SAPIEN Versus Medtronic Aortic Bioprosthesis in Women Undergoing Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry).
    Giannini C; Petronio AS; Mehilli J; Sartori S; Chandrasekhar J; Faggioni M; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail GW; Ferrer MC; Naber C; Kievit P; Sorrentino S; Morice MC; Chieffo A; Mehran R;
    Am J Cardiol; 2020 Feb; 125(3):441-448. PubMed ID: 31813530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous plug-based vascular closure device in 1000 consecutive transfemoral transcatheter aortic valve implantations.
    Kastengren M; Settergren M; Rück A; Feldt K; Saleh N; Linder R; Verouhis D; Meduri CU; Bager J; Dalén M
    Int J Cardiol; 2022 Jul; 359():7-13. PubMed ID: 35427700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcatheter aortic valve implantation with different self-expanding devices-a propensity score-matched multicenter comparison.
    Wienemann H; Hof A; Ludwig S; Veulemans V; Sedaghat A; Iliadis C; Meertens M; Macherey S; Hohmann C; Kuhn E; Al-Kassou B; Wilde N; Schofer N; Bleiziffer S; Maier O; Kelm M; Baldus S; Rudolph TK; Adam M; Mauri V
    Hellenic J Cardiol; 2023; 70():1-9. PubMed ID: 36538975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcatheter aortic valve implantation in severe calcified annulus using the Lotus valve system: Increased incidence of fatal major vascular complications.
    Conzelmann LO; Würth A; Balthasar V; Neuber C; Tzamalis P; Gonska BD; Schmitt C; Mehlhorn U; Schymik G
    Catheter Cardiovasc Interv; 2020 Jan; 95(1):E21-E29. PubMed ID: 31115146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First experience with transfemoral transcatheter aortic valve implantation without prior balloon pre-dilatation using a latest generation repositionable and retrievable transcatheter heart valve†.
    Schaefer A; Harmel E; Seiffert M; Reichart D; Deuschl F; Schofer N; Schneeberger Y; Blankenberg S; Reichenspurner H; Schaefer U; Conradi L
    Interact Cardiovasc Thorac Surg; 2017 May; 24(5):659-662. PubMed ID: 28329312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mid-term outcomes and hemodynamic performance of transcatheter aortic valve implantation in bicuspid aortic valve stenosis: Insights from the bicuSpid TAvi duraBILITY (STABILITY) registry.
    Fiorina C; Massussi M; Ancona M; Montorfano M; Petronio AS; Tarantini G; Castriota F; Chizzola G; Costa G; Tamburino C; Adamo M
    Catheter Cardiovasc Interv; 2023 Nov; 102(6):1132-1139. PubMed ID: 37668083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of coronary obstruction in patients at risk undergoing transcatheter aortic valve implantation: the Hamburg BASILICA experience.
    Westermann D; Ludwig S; Kalbacher D; Spink C; Linder M; Bhadra OD; Nikorowitsch J; Waldschmidt L; Demal T; Voigtländer L; Schaefer A; Seiffert M; Pecha S; Schofer N; Greenbaum AB; Reichenspurner H; Blankenberg S; Conradi L; Schirmer J
    Clin Res Cardiol; 2021 Dec; 110(12):1900-1911. PubMed ID: 34156524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One-year outcomes with two suture-mediated closure devices to achieve access-site haemostasis following transfemoral transcatheter aortic valve implantation.
    Mehilli J; Jochheim D; Abdel-Wahab M; Rizas KD; Theiss H; Spenkuch N; Zadrozny M; Baquet M; El-Mawardy M; Sato T; Lange P; Kuppatt C; Greif M; Hausleiter J; Bauer A; Schwarz F; Pichlmaier M; Hagl C; Richardt G; Massberg S
    EuroIntervention; 2016 Nov; 12(10):1298-1304. PubMed ID: 27866140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.